San Diego, CA, 27 January, 2026: iXCells Biotechnologies (“iXCells”), a leading provider of human cell-based solutions and ...
Organoids are an important component of translational research, particularly for evaluating drug toxicity and tissue-specific responses.
REPROCELL today announced the commercial launch of StemEdit, its clinical gene editing services and new gene-edited iPSC product lines leveraging OpenCRISPR-1™, an AI-designed genome editing system ...
Designation underscores the potential of this chemically induced, off-the-shelf cell therapy to address a high unmet need in ...
PRNewswire/ — International Health Dialogue (IHD) 2026 opened today in Hyderabad, bringing together clinicians, patient safety leaders, accreditation experts, and health system policymakers from India ...
Designation underscores potential of chemically induced, off-the-shelf cell therapy to address high unmet need in Parkinson's disease, following compelling Phase I clinical data ...
A string of clinical and regulatory milestones in the December quarter highlighted growing momentum for ASX health stocks ...
Creative Medical Technology Holdings Receives Regulatory Approval for BioDefense Burn Pit Initiative
Creative Medical Technology Holdings, Inc. - GlobeNewswire - Tue Jan 6, 8:15AM CST PHOENIX, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) (“Creative ...
Creative Medical Technology Holdings Receives Regulatory Approval for BioDefense Burn Pit Initiative
PHOENIX, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) (“Creative Medical” or the “Company”), a clinical-stage biotechnology company advancing ...
PHOENIX - Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) announced Tuesday that its BioDefense Inc. Burn Pit Initiative has received regulatory approval to proceed, allowing the company to ...
NouvNeu004: Recently received I-III all-stage IND approval from the NMPA, making it the world's first cell therapy product for Multiple System Atrophy (MSA) and iRegene's third self-developed product ...
Argano, the world's first and largest Global Specialist Consultancy exclusively focused on the design and delivery of High-Performance Business Operations with an AI-forward approach to transformation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results